September 20, 2023
Teladoc Health Appoints Leading Healthcare and Hospitals Executive Eric Evans to Board of Directors
PURCHASE, NY, Sept. 20, 2023 (GLOBE NEWSWIRE) - Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today appointed Eric Evans to the company’s board of directors. Mr. Evans, currently chief executive officer and director of Brentwood, TN-based Surgery Partners, Inc. (NASDAQ:SGRY), is a recognized healthcare and hospital executive with significant experience leading complex organizations operating at the intersection of care and technology. Mr. Evans joins the board following the retirement of Senator William Frist, M.D. earlier this year, and will serve on the board’s compensation committee.
David B. Snow, Jr., non-executive Chairman of the company’s board, said: “We are extremely pleased to welcome Eric to Teladoc Health’s board of directors. Eric brings the perfect combination of talent, experience, and mindset to today’s Teladoc Health as we work closely with our clients to enhance our services and offerings, invest in a robust innovation...
Read More
July 25, 2023
Teladoc Health Reports Second Quarter 2023 Results
Second quarter 2023 revenue grows 10% year-over-year to $652.4 million Second quarter 2023 operating cash flow of $101.2 million ; free cash flow of $64.6 million Second quarter 2023 net loss of $65.2 million , or $0.40 per share Second quarter 2023 adjusted EBITDA of $72.2 million PURCHASE, NY, July 25, 2023 (GLOBE NEWSWIRE) - Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the second quarter ended June 30, 2023. "Teladoc Health continues to set the standard for delivery of innovative, whole person virtual healthcare solutions to an ever-demanding marketplace focused on the intersection of quality and cost of care," said Jason Gorevic, chief executive officer of Teladoc Health. "For the second quarter, we are pleased to report strong financial and operating results against all key metrics, including adjusted EBITDA of $72.2 million, exceeding expectations. This performance is a direct result of...
Read More